Senin, 23 Juli 2012

gene mutations in a:in a verydenocarcinoma

gene mutations in a:in a verydenocarcinoma
kras among the first:the primary of the molecular changes of clinical
significance identified in pulmonary adenocarcinoma
was point:purpose mutation in the:within the k ras gene. this gene encodes a
membrane-associated protein that is:that's a key link in the:within the tyrosine
kinase signaling cascade in cancer cells. mutation in this:during this
gene results in a:in a very constitutively active protein that enhances cell
proliferation and i:and that induces malignant transformation. 304, 305 in
1988, rodenhuis et al. 306 reported that k ras mutation was
present in 9:nine of 35 clinical samples of adenocarcinoma and
subsequently kras mutation prevalence has ranged from
approximately 10% to 40%. 307–315 the frequency of kras
mutation increases:will increase with disease stage, 316 ranging from 12:twelve. 5%
of single nodules to 40% of tumors with satellite nodules
to 6:to six0% of cases of intrathoracic spread of tumor. initially,
kras mutation was reported as negative prognostic marker 307
but:other then the prognostic significance of mutation was not:wasn't initially
confirmed. a recent analysis of available:offered prognostic data:knowledge concludes
that kras is a:may be a weakly negative prognostic indicator. 317
there is:there's a strong:a robust association between smoking and kras mutation
in a:in a verydenocarcinoma. 318–320
tp53 point:purpose mutation in the:within the tp53 gene is also:is additionally common in
lung adenocarcinomas, occurring in 35% of these:of those tumors and
has been associated with:related to poor outcome. 321, 322 mutation is uncommon
in pure bac but:other then is found in 11% of adenocarcinomas
of mixed invasive/bac subtype and i:and that in 48% of tumors
that are purely invasive, 323 suggesting a role for tp53 in progression
to aggressive forms of invasive peripheral lung cancer.
tp53 mutation occurs in a:in a veryssociation with kras in a small:alittle
proportion ( 5%) of adenocarcinomas and appears:seems to occur
independently.

0 komentar:

Posting Komentar

 
 
Copyright © Mesothelioma.Asbestos.Lawyers